SCHEMBL5318246

SCHEMBL5318246

O=C(C=CN1CCC(C(CO)N2CCC(c3c[nH]c4ccc(F)cc34)CC2)CC1)c1cc(F)c(F)c(F)c1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320143 0.84 CCR2 (0.71) CCR2
SCHEMBL5946854 0.82 CCR2 (1.00) CCR2
SCHEMBL5318250 0.82 CCR2 (1.00) CCR2
SCHEMBL5328493 0.79 CCR2 (0.54) CCR2
SCHEMBL5349966 0.79 CCR2 (0.47) CCR2
SCHEMBL5317370 0.78 CCR2 (0.55) CCR2
SCHEMBL5947196 0.77 CCR2 (0.88) CCR2
SCHEMBL5947191 0.77 CCR2 (0.88) CCR2
SCHEMBL5947254 0.75 CCR2 (1.00) CCR2
SCHEMBL5947029 0.75 CCR2 (1.00) CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802602-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-04 EP disclosed
WO-2006036527-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-04-06 WO disclosed